ICU Medical Inc (ICUI) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.

Total Cash From Operating Activities Chart for ICU Medical Inc

ICU Medical Inc (ICUI) operating cash flow for FY2025 was USD 179.8M, a -11.9% change from FY2024. ICU Medical Inc's operating cash flow grew from USD 3.0M in 1991 to USD 179.8M in 2025 (5894.9% over 34 years). Operating cash flow compound annual growth rate: 5-year CAGR of -4.2%, 10-year CAGR of 12.6%, 20-year CAGR of 9.9%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$4.08B
Implied Share Price
$162.99
Enterprise Value
$5.00B
Revenue (TTM)
$2.16B
EBITDA
$326.12M
Profit Margin
1.39%
Trailing P/E
136.97
Forward P/E
16.95
Price/Book (MRQ)
1.87
Price/Sales (TTM)
1.89
EV/EBITDA
17.59
EV/Revenue
2.31
Dividend Yield
—
Book Value
$86.05
Free Cash Flow (FY2025)
$91.80M
Free Cash Flow Yield
2.25%

Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.